Kestra Private Wealth Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
5,848
+2,935
+101% +$570K 0.01% 765
2025
Q4
$506K Sell
2,913
-194
-6% -$35.3K 0.01% 1154
2025
Q3
$592K Buy
3,107
+477
+18% +$84.6K 0.01% 1025
2025
Q2
$472K Buy
2,630
+565
+27% +$98.1K 0.01% 1061
2025
Q1
$349K Buy
2,065
+689
+50% +$113K 0.01% 1129
2024
Q4
$208K Sell
1,376
-12
-0.9% -$1.87K ﹤0.01% 1298
2024
Q3
$215K Buy
+1,388
New +$207K ﹤0.01% 1236
2024
Q1
Sell
-1,608
Closed -$222K 1318
2023
Q4
$222K Sell
1,608
-132
-8% -$17.4K 0.01% 1070
2023
Q3
$212K Buy
+1,740
New +$232K 0.01% 1011
2023
Q2
Sell
-1,519
Closed -$215K 1098
2023
Q1
$215K Buy
+1,519
New +$217K 0.01% 899
2021
Q3
Sell
-1,602
Closed -$211K 933
2021
Q2
$211K Buy
+1,602
New +$210K 0.01% 794

Other funds holding DGX

Kestra Private Wealth Services's DGX Position: Q1 2026 in Review

Kestra Private Wealth Services increased its Quest Diagnostics (DGX) stake by 101% in Q1 2026, buying an estimated $570K and bringing the position to 5,848 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #765.

Kestra Private Wealth Services first reported a position in DGX in Q2 2021 and has held it in 11 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Kestra Private Wealth Services held 5,848 shares of Quest Diagnostics worth $1.15M as of Q1 2026.
  • Kestra Private Wealth Services bought 2,935 Quest Diagnostics shares in Q1 2026, an estimated $570K.
  • Quest Diagnostics made up 0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #765 holding.
  • Kestra Private Wealth Services first reported a position in Quest Diagnostics in Q2 2021 and has held it in 11 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.